Volume 27, Number 8—August 2021
Research
Estimates of Toxoplasmosis Incidence Based on Healthcare Claims Data, Germany, 2011–2016
Table 1
Case definitions for toxoplasmosis disease manifestations used in analysis of healthcare claims, Germany*
Toxoplasmosis manifestation | Case definition |
---|---|
Non–pregnancy-associated | |
Ocular toxoplasmosis | Patient with ICD-10 diagnosis code B58.0 |
Cerebral toxoplasmosis | Patient with ICD-10 diagnosis code B58.2 |
Hepatitis through toxoplasmosis | Patient with ICD-10 diagnosis code B58.1 |
Pneumonitis through toxoplasmosis | Patient with ICD-10 diagnosis code B58.3 |
Toxoplasmosis of other specified sites |
Patient with ICD-10 diagnosis code B58.8 |
Unspecified toxoplasmosis |
Patient with ICD-10 diagnosis code B58 or B58.9 |
Toxoplasmosis in mother and child | |
Congenital toxoplasmosis† | Children <12 mo of age with ICD-10 code P37.1 or B58.9 |
Toxoplasmosis during pregnancy‡ | Pregnant woman with ICD-10 code B58 |
AND 1 of the following laboratory tests: avidity testing (EBM 32640) or testing for Toxoplasma gondii in amniotic fluid or fetal blood (EBM 32833) | |
AND who received 1 of the following treatments: spiramycin (before 16th week of pregnancy), pyrimethamine in combination with sulfadiazine/clindamycin/atovaquone (after 16th week of pregnancy), trimethoprim/sulfamethoxazole |
*The reference population for incidence estimation for each form of toxoplasmosis was all patients in the healthcare database not fulfilling the case definition. ICD-10, International Classification of Diseases, 10th Revision. †Reference population was children <1 year of age. ‡Reference population was female patients 15–50 y of age and pregnant. Pregnancy was defined based on ICD-10 diagnostic codes indicating birth, stillbirth, abortion, or miscarriage.